HEPCLUDEX subst sèche 2 mg flac 30 pce
7680683380014
CH-68338
J05AX28
08.03.0.
Reimbursement limitations:
HEPCLUDEX.01
HEPCLUDEX est remboursé après accord sur la prise en charge des coûts par l’assurance-maladie, après …
1 / 3
google
Details
- Product number
- 6833801
- CPT
- -
- Packaging group
- 30
- Unit
- Durchstechflasche(n)
- Composition
- bulevirtidum 2 mg ut bulevirtidi acetas, natrii carbonas, natrii hydrogenocarbonas, mannitolum, pro vitro corresp. natrium 0.63 mg.
Articles (1)
Hepcludex 2 mg, Pulver zur Herstellung einer Injektionslösung
Pulver
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.63 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 5898.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2025
Authorization holder
Gilead Sciences Switzerland Sàrl
6300 Zug
Authorization information
- Swissmedic authorization number
- 68338
- Drug name
- Hepcludex, Pulver zur Herstellung einer Injektionslösung
- Galenic form
- PULVL
- ATC Code
- J05AX28
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 05/02/2024
- Authorization expiration date
- 04/02/2029
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- HEPCLUDEX subst sèche 2 mg flac 30 pce
- Description (DE)
- HEPCLUDEX Trockensub 2 mg Durchstf 30 Stk
- Market launch
- 05/02/2024
- Narcotic (BTM)
- No